Targeted Metabolomics Based on LC-MS/MS Revealing Alteration of Bile Acids in Male Migraine Patients

doi:10.1007/s40242-022-2035-8

高等学校化学研究 ›› 2022, Vol. 38 ›› Issue (3): 809-815.doi: 10.1007/s40242-022-2035-8

Targeted Metabolomics Based on LC-MS/MS Revealing Alteration of Bile Acids in Male Migraine Patients

SONG Shiyao¹, TANG Wenjing², YU Shengyuan², LIU Huwei¹, and BAI Yu¹

1. Beijing National Laboratory for Molecular Sciences, Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education, Institute of Analytical Chemistry, College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, P. R. China;
2. Department of Neurology, the First Medical Center, Chinese PLA(People's Liberation Army) General Hospital, Beijing 100853, P. R. China

收稿日期:2022-01-27 修回日期:2022-04-12 出版日期:2022-06-01 发布日期:2022-05-26
通讯作者: BAI Yu, YU Shengyuan E-mail:yu.bai@pku.edu.cn;yushengyuan@301hospital.com.cn
基金资助:
This work was supported by the Beijing Natural Science Foundation Essential Research Project, China(No.Z170002) and the National Natural Science Foundation of China(Nos.22125401, 22074003, 82071226 and 81901145).

Targeted Metabolomics Based on LC-MS/MS Revealing Alteration of Bile Acids in Male Migraine Patients

SONG Shiyao¹, TANG Wenjing², YU Shengyuan², LIU Huwei¹, and BAI Yu¹

1. Beijing National Laboratory for Molecular Sciences, Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education, Institute of Analytical Chemistry, College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, P. R. China;
2. Department of Neurology, the First Medical Center, Chinese PLA(People's Liberation Army) General Hospital, Beijing 100853, P. R. China

Received:2022-01-27 Revised:2022-04-12 Online:2022-06-01 Published:2022-05-26
Contact: BAI Yu, YU Shengyuan E-mail:yu.bai@pku.edu.cn;yushengyuan@301hospital.com.cn
Supported by:
This work was supported by the Beijing Natural Science Foundation Essential Research Project, China(No.Z170002) and the National Natural Science Foundation of China(Nos.22125401, 22074003, 82071226 and 81901145).

摘要/Abstract

摘要： Migraine is an episodic neurological disorder and the second most disabling disease with unclear pathogenesis. Since dietary adjustment and probiotics supplement can improve the symptoms of migraine, the intestinal flora metabolites of bile acids(BAs) attract attentions in this work. 21 BAs, including cholic acid(CA), chenodeoxycholic acid(CDCA), deoxycholic acid (DCA), lithocholic acid(LCA), ursodeoxycholic acid(UDCA), hyocholic acid(HCA), hyodeoxycholic acid(HDCA) and their glycine- and taurine-conjugated species, were compared in serum of migraine patients and healthy controls using liquid chromatography-tandem mass spectrometry(LC-MS/MS), which is the first study about the correlation between BAs and migraine. Two secondary BAs, DCA and LCA as well as their glycine- and taurine-conjugated forms, were demonstrated with significant difference between male patients and male controls, while no obvious difference was found in the two female groups. The result indicated that the variation of BAs might be gender-related when referred to migraine, which would emphasize the importance of gender-stratified analysis for the disease with varying morbidity in male and female. Five differential metabolites may serve as potential serum biomarkers for the male migraine patients, providing a new sight for the understanding and biomarker exploring of the migraine in male.

关键词: Migraine, Bile acid, Metabolomics, Liquid chromato-graphy-tandem mass spectrometry(LC-MS/MS), Gender-stratified analysis

Abstract: Migraine is an episodic neurological disorder and the second most disabling disease with unclear pathogenesis. Since dietary adjustment and probiotics supplement can improve the symptoms of migraine, the intestinal flora metabolites of bile acids(BAs) attract attentions in this work. 21 BAs, including cholic acid(CA), chenodeoxycholic acid(CDCA), deoxycholic acid (DCA), lithocholic acid(LCA), ursodeoxycholic acid(UDCA), hyocholic acid(HCA), hyodeoxycholic acid(HDCA) and their glycine- and taurine-conjugated species, were compared in serum of migraine patients and healthy controls using liquid chromatography-tandem mass spectrometry(LC-MS/MS), which is the first study about the correlation between BAs and migraine. Two secondary BAs, DCA and LCA as well as their glycine- and taurine-conjugated forms, were demonstrated with significant difference between male patients and male controls, while no obvious difference was found in the two female groups. The result indicated that the variation of BAs might be gender-related when referred to migraine, which would emphasize the importance of gender-stratified analysis for the disease with varying morbidity in male and female. Five differential metabolites may serve as potential serum biomarkers for the male migraine patients, providing a new sight for the understanding and biomarker exploring of the migraine in male.

Key words: Migraine, Bile acid, Metabolomics, Liquid chromato-graphy-tandem mass spectrometry(LC-MS/MS), Gender-stratified analysis

SONG Shiyao, TANG Wenjing, YU Shengyuan, LIU Huwei, and BAI Yu. Targeted Metabolomics Based on LC-MS/MS Revealing Alteration of Bile Acids in Male Migraine Patients[J]. 高等学校化学研究, 2022, 38(3): 809-815.

SONG Shiyao, TANG Wenjing, YU Shengyuan, LIU Huwei, and BAI Yu. Targeted Metabolomics Based on LC-MS/MS Revealing Alteration of Bile Acids in Male Migraine Patients[J]. Chemical Research in Chinese Universities, 2022, 38(3): 809-815.

参考文献

[1] Launer L. J., Terwindt G. M., Ferrari M. D., Neurology, 1999, 53(3), 537
[2] Jensen R., Stovner L. J., Lancet Neurol., 2008, 7(4), 354
[3] Vos T., Abajobir A. A., Abbafati C., Abbas K. M., Abate K. H., Abd-Allah F., Abdulle A. M., Abebo T. A., Abera S. F., Aboyans V., et al., Lancet, 2017, 390(10100), 1211
[4] Yao C. Y., Wang Y., Wang L. J., Liu Y. N., Liu J. M., Qi J. L., Lin Y., Yin P., Zhou M. G., J. Headache Pain, 2019, 20(1), 11
[5] Bes A., Kunkel R., Lance J. W., Nappi G., Pfaffenrath V., Rose F. C., Schoenberg B. S., Soyka D., Tfelt-Hansen P., Welch K. M. A., et al., Cephalalgia, 2013, 33(9), 629
[6] Martami F., Togha M., Seifishahpar M., Ghorbani Z., Ansari H., Karimi T., Jahromi S. R., Cephalalgia, 2019, 39(7), 841
[7] Bajaj J. S., Nat. Rev. Gastroenterol. Hepatol., 2019, 16(4), 235
[8] Jackson M. A., Verdi S., Maxan M. E., Shin C. M., Zierer J., Bowyer R. C. E., Martin T., Williams F. M. K., Menni C., Bell J. T., Spector T. D., Steves C. J., Nat. Commun., 2018, 9, 8
[9] Ma E. L., Smith A. D., Desai N., Cheung L. M., Hanscom M., Stoica B. A., Loane D. J., Shea-Donohue T., Faden A. I., Brain Behav. Immun., 2017, 66, 56
[10] Dahlin M., Prast-Nielsen S., EBioMedicine, 2019, 44, 741
[11] Sharon G., Cruz N. J., Kang D. W., Gandal M. J., Wang B., Kim Y. M., Zink E. M., Casey C. P., Taylor B. C., Lane C. J., Bramer L. M., Isern N. G., Hoyt D. W., Noecker C., Sweredoski M. J., Moradian A., Borenstein E., Jansson J. K., Knight R., Metz T. O., Lois C., Geschwind D. H., Krajmalnik-Brown R., Mazmanian S. K., Cell, 2019, 177(6), 1600
[12] Li B. Y., He Y. X., Ma J. F., Huang P., Du J. J., Cao L., Wang Y., Xiao Q., Tang H. D., Chen S. D., Alzheimers. Dement., 2019, 15(10), 1357
[13] Tang Y. Y., Liu S. F., Shu H., Yanagisawa L., Tao F., Mol. Neurobiol., 2020, 57(1), 461
[14] Wen Z. Q., He M. Z., Peng C. Y., Rao Y. F., Li J. M., Li Z. F., Du L. J., Li Y., Zhou M. F., Hui O., Feng Y. L., Yang S. L., Front. Pharmacol., 2019, 10, 1
[15] Grasset E., Burcelin R., Rev. Endocr. Metab. Disord., 2019, 20(4), 427
[16] Anderson G., Curr. Pharm. Design, 2019, 25(33), 3550
[17] Vallim T. Q. D., Tarling E. J., Edwards P. A., Cell Metab., 2013, 17(5), 657
[18] Wahlstrom A., Sayin S. I., Marschall H. U., Backhed F., Cell Metab., 2016, 24(1), 41
[19] Chiang J. Y. L., J. Lipid Res., 2009, 50(10), 1955
[20] Gerard P., Pathogens (Basel, Switzerland), 2013, 3(1), 14
[21] Schneider K. M., Albers S., Trautwein C., J. Hepatol., 2018, 68(5), 1083
[22] Ma C., Han M. J., Heinrich B., Fu Q., Zhang Q. F., Sandhu M., Agdashian D., Terabe M., Berzofsky J. A., Fako V., Ritz T., Longerich T., Theriot C. M., McCulloch J. A., Roy S., Yuan W. X., Thovarai V., Sen S. K., Ruchirawat M., Korangy F., Wang X. W., Trinchieri G., Greten T. F., Science, 2018, 360(6391), 9
[23] Voiosu A., Wiese S., Voiosu T., Bendtsen F., Moller S., Liver Int., 2017, 37(10), 1420
[24] Yu Q. W., Jiang Z. Z., Zhang L. Y., Pharmacol. Ther., 2018, 190, 81
[25] Luyckx E., Eyskens F., Simons A., Beckx K., Van West D., Dhar M., Clin. Neurol. Neurosurg., 2014, 118, 9
[26] Camara-Lemarroy C. R., Metz L. M., Yong V. W., World J. Gastroenterol., 2018, 24(37), 4217
[27] Nho K., Kueider-Paisley A., MahmoudianDehkordi S., Arnold M., Risacher S. L., Louie G., Blach C., Baillie R., Han X. L., Kastenmuller G., et al., Alzheimers. Dement., 2019, 15(2), 232
[28] McMillin M., DeMorrow S., Faseb J., 2016, 30(11), 3658
[29] Kiriyama Y., Nochi H., Biomolecules, 2019, 9(6), 1
[30] Shen S. S., Yang L., Li L. N., Bai Y., Liu H. W., Analytica Chimica Acta, 2018, 1037(1), 75
[31] Yu Z. M., Peng Q., Li S. Y., Hao H. J., Deng J. W., Meng L. B., Shen Z. Y., Yu W. W., Ding N., Bai Y., Huang Y. N.,Clinical Sci., 2020, 134(5), 439
[32] MacDonald I. A., White B. A., Hylemon P. B., J. Lipid Res., 1983, 24(9), 1119
[33] Ridlon J. M., Bajaj J. S., Acta Pharmaceutica Sinica B, 2015, 5(2), 99
[34] Doerner K. C., Takamine F., LaVoie C. P., Mallonee D. H., Hylemon P. B., Appl. Environ. Microbiol., 1997, 63(3), 1185
[35] Midtvedt T., Am. J. Clin. Nutr., 1974, 27(11), 1341
[36] Ridlon J. M., Kang D. J., Hylemon P. B., J. Lipid Res., 2006, 47(2), 241
[37] Kitahara M., Takamine F., Imamura T., Benno Y., Int. J. Syst. Evol. Microbiol., 2000, 50(3), 971
[38] Ridlon J. M., Kang D. J., Hylemon P. B., Bajaj J. S., Curr. Opin. Gastroenterol., 2014, 30(3), 332
[39] Maruyama T., Miyamoto Y., Nakamura T., Tamai Y., Okada H., Sugiyama E., Nakamura T., Itadani H., Tanaka K., Biochem. Biophys. Res. Commun., 2002, 298(5), 714
[40] Ren C., Liu J., Zhou J., Liang H., Wang Y., Sun Y., Ma B., Yin Y., Biochem. Biophys. Res. Commun., 2018, 496(2), 267
[41] Peterlin B. L., Mielke M. M., Dickens A. M., Chatterjee S., Dash P., Alexander G., Vieira R. V., Bandaru V. V. R., Dorskind J. M., Tietjen G. E., Haughey N. H., Neurology, 2015, 85(14), 1214
[42] Thompson P. A., Wertheim B. C., Roe D. J., Ashbeck E. L., Jacobs E. T., Lance P., Martinez M. E., Alberts D. S., Cancer Prev. Res., 2009, 2(12), 1023
[43] Trottier J., Caron P., Straka R. J., Barbier O., Clin. Pharmacol. Ther., 2011, 90(2), 279
[44] Heubi J. E., Setchell K. D. R., Bove K. E., Semin. Liver Dis., 2007, 27(3), 282
[45] Pan X. B., Elliott C. T., McGuinness B., Passmore P., Kehoe P. G., Holscher C., McClean P. L., Graham S. F., Green B. D., Metabolites, 2017, 7(2), 1
[46] Jia W., Rajani C., Kaddurah-Daouk R., Li H. K., Med. Res. Rev., 2020, 40(4), 1496

Targeted Metabolomics Based on LC-MS/MS Revealing Alteration of Bile Acids in Male Migraine Patients

Targeted Metabolomics Based on LC-MS/MS Revealing Alteration of Bile Acids in Male Migraine Patients

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 2

编辑推荐

Metrics

本文评价

[1]	XIAO Chulei, CHI Quan, WANG Xian. Recent Progress in Mass Spectrometry-based Metabolomics for Colorectal Cancer[J]. 高等学校化学研究, 2022, 38(4): 886-893.
[2]	SHI Cheng-he, ZHAO Hui-hui, HOU Na, CHEN Jian-xin, SHI Qi, XU Xue-gong, WA. Identifying Metabolite and Protein Biomarkers in Unstable Angina In-patients by Feature Selection Based Data Mining Method[J]. 高等学校化学研究, 2011, 27(1): 87-93.